Original Article

A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis

Sugarman, J.L, et al.

BACKGROUND: Psoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression. Treatment options focus on relieving symptoms, reducing inflammation, induration, and scaling, and controlling the extent of the disease. T.......

Read more

Original Article

Topical Approaches to Improve Surgical Outcomes and Wound Healing: A Review of Efficacy and Safety

Totoraitis, K., et al.

Surgical procedures are an important piece of a dermatologist’s daily practice. Therefore, the optimization of post-surgical wound healing is an area of utmost importance and interest. Although low risk, one notable barrier to proper wound healin.......

Read more

Original Article

Use of Biologics in Private Practice: Nine Years of Lessons and Learning

Correa-Selm, L.M. et al.

Over a decade ago, the FDA approved biologics for psoriasis, which changed how the disease is treated and, in most cases, has a significant positive impact on the lives of patients. Side effects primarily identified during the investigational and.......

Read more

Original Article

Patient Preference for Dosing Frequency Based on Prior Biologic Experience

Zhang, M. et al.

Background: There is limited research exploring patient preferences regarding dosing frequency of biologic treatment of psoriasis. Methods: Patients with moderate-to-severe plaque psoriasis identified in a healthcare claims database completed a surv.......

Read more

Original Article

Dermatologists: Collaborating With Payers to Optimize Coverage Policies

Amato, D. A. et al.

Dermatologists are frustrated by payer constraints that limit their ability to optimize patient treatment. They can benefit from understanding the payer formulary process and places in that process where they can exert influence.

Collaboration bet.......

Read more

Original Article

Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis

Pariser, D. et al.

BACKGROUND: A novel lotion formulation of halobetasol propionate, 0.05% (HBP Lotion) with enhanced vehicle characteristics of a cream while preserving the ease of use and cosmetic elegance of a lotion has been developed to treat plaque psoriasis. .......

Read more

Original Article

Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream

Zirwas, M.J. et al.

Objective: To evaluate the speed of onset and duration of relief of two ceramide-containing formulations with 1% pramoxine hydroxide (CeraVe® Itch Relief Lotion and Cream,Valeant Pharmaceuticals North America LLC, Irvine, CA) in patients with atop.......

Read more

Original Article

Treatment of Atopic Dermatitis in the United States: Analysis of Data from the National Ambulatory Medical Care Survey

McGregor, S.P. et al.

Introduction: Atopic dermatitis (AD) affects both adult and pediatric patients, and multiple practitioners encounter and manage AD. However, differences with regard to the treatment of AD between specialties are not well characterized. Objective:.......

Read more

Original Article

Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis

Berman, B. et al.

Dermatologists treat actinic keratosis (AK) primarily because these lesions have the potential to progress to invasive squamous cell carcinoma. Patients, on the other hand, generally seek treatment to remove the lesions and achieve an improved app.......

Read more